NEUMANN MARK

PrivateCIK: 1756211
Location

BEDMINSTER, NJ

NEUMANN MARK (EVP, Chief Commercial Officer) reported 1 transaction at INTRA-CELLULAR THERAPIES, INC.

Review the transaction codes below to understand the nature of each event.

InsiderNEUMANN MARKCIK 1756211
Officer· EVP, Chief Commercial Officer
Since Oct 2018
-124.07K
Net shares
Net seller
$6.97M
Total sold
0
Open market trades
0B · 0S
9
Total transactions
21.88K acquired · 145.95K disposed
Non-Derivative Transactions1

Common Stock

Direct
D · Disposition

Shares

52.81K

Price / share

$132.00

Trade value

$6.97M

% of position

New position
4/2/2025
52.81K0.00
Total

Net shares

52.81K

Net value

-$6.97M

Derivative Transactions8

Stock Option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

17.92K shares

Shares

17.92K

Strike price

56.73

Held after

0.00

Exercisable

4/2/2025

Restricted Stock Units

Direct
D · Disposition
Converts to

Common Stock

13.13K shares

Shares

13.13K

Strike price

Held after

0.00

Exercisable

4/2/2025

Restricted Stock Units

Direct
D · Disposition
Converts to

Common Stock

17.48K shares

Shares

17.48K

Strike price

Held after

0.00

Exercisable

4/2/2025

Restricted Stock Units

Direct
D · Disposition
Converts to

Common Stock

22.73K shares

Shares

22.73K

Strike price

Held after

0.00

Exercisable

4/2/2025

Performance Stock Units

Direct
A · Award
Converts to

Common Stock

13.13K shares

Shares

+13.13K

Strike price

Held after

13.13K

Exercisable

4/2/2025

Performance Stock Units

Direct
D · Disposition
Converts to

Common Stock

13.13K shares

Shares

13.13K

Strike price

Held after

0.00

Exercisable

4/2/2025

Performance Stock Units

Direct
A · Award
Converts to

Common Stock

8.74K shares

Shares

+8.74K

Strike price

Held after

8.74K

Exercisable

4/2/2025

Performance Stock Units

Direct
D · Disposition
Converts to

Common Stock

8.74K shares

Shares

8.74K

Strike price

Held after

0.00

Exercisable

4/2/2025
NEUMANN MARK — Insider Transaction (Form 4) Filed Apr 2, 2025 | Finecho